Auwaerter on Infectious Diseases

• Baloxavir's Place in the Treatment of Flu   We are learning more about baloxavir and how it differs from existing antiviral drugs for treating influenza. Paul Auwaerter describes the drug's potential advantages.
  Medscape Infectious Diseases, February 2019
• Are Showerheads Causing Chronic Lung Infections?   An ecologic study reveals the US hotspots for showerhead biofilms contaminated with mycobacteria and a geographical correlation with nontuberculous mycobacterial lung disease.
  Medscape Infectious Diseases, December 2018
• Oral Antibiotics for Infective Endocarditis: Time to Switch?   The standard of care for endocarditis for many years has been IV antibiotics, even though many patients don't complete the full treatment. Would oral antibiotics work just as well?
  Medscape Infectious Diseases, October 2018
• Fever of Unknown Origin in an Adult-- Periodic Fever Syndromes?   Dr Paul Auwaerter highlights syndromes associated with recurrent fever in adults.
  Medscape Infectious Diseases, July 2018
• A Call for a Lyme Disease Vaccine   With the increase in vector-borne disease, we need more than an ounce of prevention. What we really need is a vaccine for Lyme disease.
  Medscape Infectious Diseases, May 2018
• Consulting an ID Specialist Saves Lives and Money   The value in consulting ID in the management of serious infections is revealed by this recent analysis.
  Medscape Infectious Diseases, April 2018
• Influenza and MRSA Pneumonia   Dr Paul Auwaerter discusses the antimicrobial options for postinfluenza MRSA pneumonia, and makes the case for a universal flu vaccine.
  Medscape Infectious Diseases, March 2018
• A New Way ID Care Is Valued   Dr Paul Auwaerter urges infectious diseases clinicians to review and incorporate into their practice two new CPT codes for prolonged services without direct face-to-face patient contact.
  Medscape Infectious Diseases, January 2018
• California Contagion: How to Control Severe Hepatitis A   Dr Paul Auwaerter discusses California's hepatitis A outbreak and the challenges of testing to avoid false-positives.
  Medscape Infectious Diseases, December 2017
• CMV Disease in the Non-immunosuppressed ICU Patient   Is CMV just a bystander or is it a contributor to critical illness in non-immunosuppressed ICU patients? A new study provides a few answers and raises new questions.
  Medscape Infectious Diseases, October 2017
• Add Legionella to Your Differential Diagnosis for Pneumonia   Don't forget to consider Legionella as a cause of hospital-acquired pneumonia. It's more common and deadlier than some may realize.
  Medscape Infectious Diseases, August 2017
• No New Antibiotics? Go to the Attic, Build Better Mousetraps   Frustrated by the slow development of new antibiotics? Paul Auwaerter, MD, offers a quick review of some of the latest approaches to this problem.
  Medscape Infectious Diseases, June 2017
• Sepsis Guidelines and Antibiotics: Going a Bit Too Far?   Dr Paul Auwaerter points out some of his ID-related concerns with the revised sepsis guidelines.
  Medscape Infectious Diseases, May 2017
• C difficile: Why Good ID Advice Still Matters   Dr Paul Auwaerter addresses some misunderstandings about the management of Clostridium difficile infection that he discovered during his time on a consultation service.
  Medscape Infectious Diseases, March 2017
• Lyme Disease: Treat Mice to Treat Ourselves?   Dr Paul Auwaerter discusses a scientist's proposal to rid areas prone to Lyme disease by making the mice immune to infection with Borrelia burgdorferi, thus breaking the transmission cycle.
  Medscape Infectious Diseases, January 2017
• Candida auris: Time to Prick Up Your Ears?   Candida auris: Have you heard of it yet? Dr Auwaerter discusses this newly identified and potentially drug-resistant isolate and tells clinicians to be on the lookout.
  Medscape Infectious Diseases, December 2016
• Antimicrobial Resistance Hits Global Stage at UN Summit   Paul Auwaerter, MD, had the privilege of representing IDSA at the United Nations meeting on antimicrobial resistance. He offers his thoughts about the experience and resulting global action plan.
  Medscape Infectious Diseases, November 2016
• Vertebral Osteomyelitis: Is 6 Weeks of Treatment Not Enough?   Paul Auwaerter is rethinking his own clinical practice for treating persistent vertebral osteomyelitis.
  Medscape Infectious Diseases, September 2016
• Tried and True: Our Best Advice for Preventing Tickborne Disease   It may not all be evidence-based, but many of these tick-avoidance strategies stand the test of time.
  Medscape Infectious Diseases, July 2016
• An Inevitable Invasion: When a Last-Resort Antibiotic Is Not an Option   The news we hoped would never come: The last of the last-resort antibiotics will not work. Now what?
  Medscape Infectious Diseases, June 2016